On the other hand, they had a lower frequency of BCR/ABL1, poor risk, TKI therapy, CR, and salvage chemotherapy, low-intensity therapy, PR, IT chemotherapy for CNS infiltration, and cranial irradiation when compared to ALL cases (Table 1). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.